Frederik Damm

Prof. Dr. med. Frederik Damm is a Professor and Managing Senior Physician at the Department of Hematology, Oncology and Cancer Immunology at Charité – University Medicine Berlin (Campus Virchow-Klinikum). He serves as Director of the Molecular Cancer Research Center (MKFZ) and leads research initiatives in clonal hematopoiesis, leukemia genomics, and immunotherapeutic applications.

• Primary Affiliation: Charité – University Medicine Berlin
• Leadership: Director of the Molecular Cancer Research Center (MKFZ)

Research Focus: Dr. Damm investigates clonal hematopoiesis, tumor heterogeneity in AML and lymphomas, and therapeutic resistance mechanisms. His work integrates genomic profiling, epigenetics, and machine learning for outcome prediction in hematologic malignancies.

Article Trends: Recent publications emphasize clonal evolution in cancers, CAR T-cell therapy applications across hematologic and autoimmune diseases, and genomic aberrations in AML and lymphomas. Collaborative efforts with the HARMONY Alliance highlight big data approaches to refine treatment strategies.

Technical Networks: Dr. Damm collaborates with the HARMONY Alliance and contributes to precision oncology through next-generation sequencing, CRISPR modeling, and international clinical trial datasets.